BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28803992)

  • 1. P-REX1 amplification promotes progression of cutaneous melanoma via the PAK1/P38/MMP-2 pathway.
    Wang J; Hirose H; Du G; Chong K; Kiyohara E; Witz IP; Hoon DSB
    Cancer Lett; 2017 Oct; 407():66-75. PubMed ID: 28803992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis.
    Qin J; Xie Y; Wang B; Hoshino M; Wolff DW; Zhao J; Scofield MA; Dowd FJ; Lin MF; Tu Y
    Oncogene; 2009 Apr; 28(16):1853-63. PubMed ID: 19305425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
    Dillon LM; Bean JR; Yang W; Shee K; Symonds LK; Balko JM; McDonald WH; Liu S; Gonzalez-Angulo AM; Mills GB; Arteaga CL; Miller TW
    Oncogene; 2015 Jul; 34(30):3968-76. PubMed ID: 25284585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide exchange factor for Rac, mediates angiogenic responses to stromal cell-derived factor-1/chemokine stromal cell derived factor-1 (SDF-1/CXCL-12) linked to Rac activation, endothelial cell migration, and in vitro angiogenesis.
    Carretero-Ortega J; Walsh CT; Hernández-García R; Reyes-Cruz G; Brown JH; Vázquez-Prado J
    Mol Pharmacol; 2010 Mar; 77(3):435-42. PubMed ID: 20018810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments.
    Campbell AD; Lawn S; McGarry LC; Welch HC; Ozanne BW; Norman JC
    PLoS One; 2013; 8(1):e53982. PubMed ID: 23382862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.
    Lindsay CR; Lawn S; Campbell AD; Faller WJ; Rambow F; Mort RL; Timpson P; Li A; Cammareri P; Ridgway RA; Morton JP; Doyle B; Hegarty S; Rafferty M; Murphy IG; McDermott EW; Sheahan K; Pedone K; Finn AJ; Groben PA; Thomas NE; Hao H; Carson C; Norman JC; Machesky LM; Gallagher WM; Jackson IJ; Van Kempen L; Beermann F; Der C; Larue L; Welch HC; Ozanne BW; Sansom OJ
    Nat Commun; 2011 Nov; 2():555. PubMed ID: 22109529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovostatin 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells.
    Huang YX; Song H; Tao Y; Shao XB; Zeng XS; Xu XL; Qi JL; Sun JF
    PLoS One; 2018; 13(4):e0195610. PubMed ID: 29684087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-REX1, a Rac guanine exchange factor, links melanocyte development and melanoma progression.
    Walker G
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1086-7. PubMed ID: 22216451
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
    Li A; Ma Y; Jin M; Mason S; Mort RL; Blyth K; Larue L; Sansom OJ; Machesky LM
    J Invest Dermatol; 2012 Nov; 132(11):2610-21. PubMed ID: 22718121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.
    Hernández-Negrete I; Carretero-Ortega J; Rosenfeldt H; Hernández-García R; Calderón-Salinas JV; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J
    J Biol Chem; 2007 Aug; 282(32):23708-15. PubMed ID: 17565979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.
    Damoulakis G; Gambardella L; Rossman KL; Lawson CD; Anderson KE; Fukui Y; Welch HC; Der CJ; Stephens LR; Hawkins PT
    J Cell Sci; 2014 Jun; 127(Pt 11):2589-600. PubMed ID: 24659802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel prognostic marker SPOCK2 regulates tumour progression in melanoma.
    Kang JY; Cho H; Gil M; Lee H; Park S; Kim KE
    Exp Dermatol; 2024 Jun; 33(6):e15092. PubMed ID: 38888196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PtdIns(3,4,5)P
    Srijakotre N; Liu HJ; Nobis M; Man J; Yip HYK; Papa A; Abud HE; Anderson KI; Welch HCE; Tiganis T; Timpson P; McLean CA; Ooms LM; Mitchell CA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28056-28067. PubMed ID: 33097662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1.
    Pan D; Barber MA; Hornigold K; Baker MJ; Toth JM; Oxley D; Welch HC
    J Biol Chem; 2016 Mar; 291(12):6359-75. PubMed ID: 26792863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive RAC activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression.
    Dalton LE; Kamarashev J; Barinaga-Rementeria Ramirez I; White G; Malliri A; Hurlstone A
    J Invest Dermatol; 2013 Jun; 133(6):1572-81. PubMed ID: 23337888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases.
    Ye RD
    Pharmacol Res; 2020 Mar; 153():104676. PubMed ID: 32006571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits.
    Adame-García SR; Cervantes-Villagrana RD; Orduña-Castillo LB; Del Rio JC; Gutkind JS; Reyes-Cruz G; Taylor SS; Vázquez-Prado J
    J Biol Chem; 2019 Feb; 294(7):2232-2246. PubMed ID: 30530493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
    Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
    Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.